Inventor · disambiguated record
Yuntao Wu
Also filed as: WU YUNTAO
19 granted patents·16 pending applications·26 citations·filing 2004–2024
90Inventor score
Files withVIRONGY L L C8UNIV GEORGE MASON7UNIV TENNESSEE RES FOUND6WU YUNTAO6GEORGE MASON INTELLECTUAL PROP2
Top patents by PatentIndex Score
35 records- 0193US11382967B2Method and system for inactivating virus infectivity for producing live-attenuated vaccinesUNIV GEORGE MASON·Filed 2020·Granted Jul 12, 2022·4 cites·19 claims
- 0290US11377499B2Targeting the cofilin pathwayUNIV GEORGE MASON·Filed 2018·Granted Jul 5, 2022·5 cites·19 claims
- 0388US10591617B2Perovskite-type halides and methods thereofUNIV TENNESSEE RES FOUND·Filed 2018·Granted Mar 17, 2020·5 cites·30 claims
- 0486US11116833B2Method and system for inactivating virus infectivity for producing live-attenuated vaccinesUNIV GEORGE MASON·Filed 2019·Granted Sep 14, 2021·3 cites·15 claims
- 0579US10838083B2Alkali and alkaline earth halides and methods thereofUNIV TENNESSEE RES FOUND·Filed 2019·Granted Nov 17, 2020·1 cites·19 claims
- 0678US7662547B2Compositions and methods for detecting and treating HIV infectionsGEORGE MASON INTELLECTUAL PROP·Filed 2007·Granted Feb 16, 2010·4 cites·6 claims
- 0776US2025051411A1Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogensVIRONGY L L C·Filed 2024·Application pending·0 cites
- 0871US2023193127A1Lutetium based oxyorthosilicate scintillators codoped with transition metalsUNIV TENNESSEE RES FOUND·Filed 2022·Application pending·0 cites
- 0968USD1009044SProtective case for tablet PCWU YUNTAO·Filed 2022·Granted Dec 26, 2023·4 cites·1 claims
- 1068US11560515B2Lutetium based oxyorthosilicate scintillators codoped with transition metalsUNIV TENNESSEE RES FOUND·Filed 2020·Granted Jan 24, 2023·0 cites·7 claims
- 1166US11474264B2Self-assembled directionally solidified eutectics for thermal neutron detectionUNIV TENNESSEE RES FOUND·Filed 2021·Granted Oct 18, 2022·0 cites·17 claims
- 1265US2021261635A1Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogensVIRONGY L L C·Filed 2021·Application pending·0 cites
- 1363US11028138B2Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogensVIRONGY L L C·Filed 2017·Granted Jun 8, 2021·0 cites·15 claims
- 1459US11732042B2Compositions and methods for using the CD2-based signaling pathways to block HIV infectionWU YUNTAO·Filed 2018·Granted Aug 22, 2023·0 cites·10 claims
- 1559US11230667B2Garnet scintillator co-doped with monovalent ionUNIV TENNESSEE RES FOUND·Filed 2019·Granted Jan 25, 2022·0 cites·25 claims
- 1659US2024173397A1Limiting viral infection and replication in stem cellsUNIV GEORGE MASON·Filed 2023·Application pending·0 cites
- 1758US12259388B2Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapyVIRONGY L L C·Filed 2019·Granted Mar 25, 2025·0 cites·2 claims
- 1857US10793876B2Retro- and lenti-HBV hybrid vectors and constructsVIRONGY L L C·Filed 2017·Granted Oct 6, 2020·0 cites·9 claims
- 1956US10793864B2Methods and compositions for assessing viral nuclear localizationUNIV GEORGE MASON·Filed 2016·Granted Oct 6, 2020·0 cites·24 claims
- 2055US2024108687A1Compositions and methods for using combinations of actin-based peptides to modulate cellular bioactivityVIRONGY L L C·Filed 2022·Application pending·0 cites
- 2154US12048741B2Recombinant host cell with heterologous nucleic acids encoding SHREK proteinsUNIV GEORGE MASON·Filed 2020·Granted Jul 30, 2024·0 cites·13 claims
- 2254US11473064B2Hybrid alphavirus-SARS-CoV-2 particle and methodology of making and using sameGEORGE MASON RES FOUNDATION INC·Filed 2021·Granted Oct 18, 2022·0 cites·20 claims
- 2352US2021236583A1Targeting the renin-angiotensin system for treatment of environment-and pathogen-induced lung injuryWU YUNTAO·Filed 2021·Application pending·0 cites
- 2452US2023235219A1Low-dimensional perovskite-structured metal halide and preparation method and application thereofSHANGHAI INST CERAMICS CAS·Filed 2021·Application pending·0 cites
- 2551US11850281B2Rev-dependent lentiviral vaccine particles for reducing viral rebound and viral reservoirs in vivoWU YUNTAO·Filed 2018·Granted Dec 26, 2023·0 cites·7 claims
- 2651US2020299139A1Compositions and methods for using activated carbon particles for purification of nucleic acidsVIRONGY L L C·Filed 2020·Application pending·0 cites
- 2750US2010292181A1Compositions and methods for detecting and treating hiv infectionsGEORGE MASON INTELLECTUAL PROP·Filed 2009·Application pending·0 cites
- 2848US12194087B2Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virionsUNIV GEORGE MASON·Filed 2020·Granted Jan 14, 2025·0 cites·20 claims
- 2948US2011207800A1HIV-Dependent expression constructs and uses thereforeWU YUNTAO·Filed 2009·Application pending·0 cites
- 3047US2007134767A1Hiv-dependent expression constructs and uses thereforUS GOV HEALTH & HUMAN SERV·Filed 2004·Application pending·0 cites
- 3145US2013303479A1Antiretroviral Cyclonucleoside Compositions and Methods and Articles of Title of Invention Manufacture TherewithHAWLEY TODD WILLIAM·Filed 2012·Application pending·0 cites
- 3240US2018172629A1Electrophoresis apparatus and use thereofVIRONGY L L C·Filed 2017·Application pending·0 cites
- 3339US2011104789A1Non-integrating rev-dependent lentiviral vector and methods of using the sameWU YUNTAO·Filed 2010·Application pending·0 cites
- 3437US2020340055A1Use of tm9sf1 gene as target in vascular diseasesUNIV HUBEI ARTS & SCIENCE·Filed 2018·Application pending·0 cites
- 3536US2019292189A1Lim kinase inhibitorsVIRONGY LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuntao Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →